CFMG & Wellpath in California — a documentary investigation · Article 015 of 100 · Series 2 — Inside the management agreement

Physician Pay as a Control Boundary: Compensation Inside the CFMG–Wellpath MSA

Published

20 September 2026, 6:00 PM PT

Content last changed

20 September 2026, 6:00 PM PT

Public-evidence cutoff

20 September 2026, 6:00 PM PT

Sources checked

20 September 2026, 6:00 PM PT

Record through

20 September 2026, 6:00 PM PT

Editorial status

Public-source editorial review complete

Evidence note. This article relies on public records and distinguishes established fact, party position, allegation, judicial finding, inference and unresolved question. Nothing here is a finding that any identified corporation or individual violated California law unless a cited adjudicative source expressly says so.

Opening frame#

Physician Pay as a Control Boundary: Compensation Inside the CFMG–Wellpath MSA turns on the difference between authority written on paper and authority demonstrated in operation. The analysis reads the management-services architecture as a division of functions, then tests whether the economic and administrative structure supports, constrains, or leaves unanswered the professional authority formally reserved to CFMG.

The governing question is narrow: When does administrative compensation design become relevant to physician autonomy? The article connects that question to juridical identity, operational integration, professional authority, ownership and succession, practical exit rights, and demonstrated veto power only where the evidence makes those connections material.

I. The Question and the Public Record#

The relevant public record is best read cumulatively. No single branding statement, county agenda item, corporate filing, bankruptcy disclosure, or management agreement resolves the entire relationship. The evidentiary value comes from comparing documents created for different purposes and asking whether they converge on the same allocation of identity, authority, economics, and professional responsibility.

II. Structural and Historical Context#

III. The Control and Governance Analysis#

2018: Correct Care Solutions and CMGC combine#

On October 1, 2018, H.I.G. announced that one of its affiliates had acquired Correct Care Solutions and combined it with its existing portfolio company, Correctional Medical Group Companies.

H.I.G. described CMGC as having been founded in 1983 “as California Forensic Medical Group.” It described the new CCS-CMGC enterprise as a national provider operating across correctional and behavioral-health settings. H.I.G., Oct. 1, 2018

This is an important enterprise-level event.

It should not be overread as proof that the California professional corporation legally merged out of existence.

Why physician workload belongs in the analysis#

One of the most significant parts of the Medical Board’s guidance is its express treatment of workload.

The Board lists both:

• how many patients a physician must see; and

• how many hours a physician must work

as physician decisions.

That matters in correctional healthcare because staffing, census, contractual service levels and custody operations can all influence workload.

An investigation therefore has to distinguish among:

• a County’s contractual staffing requirement;

• an MSO’s workforce recommendation;

• a professional corporation’s physician-staffing decision;

• and an individual physician’s patient-specific clinical judgment.

Those are different sources of authority.

Records, coding and equipment are not merely back-office subjects#

The same point applies to systems that may look administrative.

A management company can provide recordkeeping technology.

But the Board treats substantive control of medical records as a physician issue.

A management company can process billing.

But the Board identifies coding and billing procedures as an area of physician control.

A management company can procure equipment.

But the Board includes approval of medical equipment and supplies in its physician-control guidance.

The analysis therefore turns on the difference between administration and final substantive authority .

Inside the CFMG–Wellpath Management Architecture#

The 2012 CFMG Management Services Agreement is unusually revealing. It formally reserves professional medicine to CFMG while assigning the management company a wide operating role across employment, finance, records, information systems, insurance, claims and other administrative functions. The contract therefore supports both professional separation and deep operational integration.

Many discussions of management-services organizations fail because they start with a conclusion.

Either the MSO is described as a routine back-office vendor, or its broad involvement is treated as proof that it controls the medical practice.

CFMG’s publicly filed management agreement makes both shortcuts difficult.

The contract contains unusually explicit language protecting physician authority.

It also gives the manager unusually broad responsibilities.

The document is therefore best read as an authority map .

Layer four: physician staffing — recommendation versus final decision#

The agreement creates a useful natural test of authority.

It says the management company will periodically review and make recommendations regarding the appropriate number of physicians needed to operate the practice sites.

But it also says final determinations concerning physician staffing levels are the responsibility of CFMG.

That division can be written as:

Wellpath/manager: review + recommend

CFMG: final determination

This is exactly the kind of allocation that should be tested in public records.

Routine agreement between the two actors tells us little.

A disagreement would tell us much more.

If a management recommendation was rejected or modified by CFMG and the CFMG decision was implemented, that would be strong evidence of practical professional veto.

If the opposite occurred, it would raise a different question.

At present, the public contract establishes the formal allocation. Later pages will search for implementation evidence.

Layer five: professional functions assigned to CFMG#

Section 3.4 assigns CFMG responsibility, in consultation with the manager, for several functions near the heart of professional governance.

These include:

• utilization review and quality-assurance guidelines;

• physician documentation;

• physician corrective action;

• credentialing physicians for specific procedures;

• handling impaired physicians;

• and policies of a purely medical nature.

The contract therefore does not simply say “CFMG handles medicine” in general terms.

It identifies particular areas where CFMG is supposed to remain responsible.

For the public investigation, those categories become testable domains.

Layer nine: insurance, risk, claims and litigation#

The management agreement assigns the manager a role in obtaining or maintaining insurance, risk-management support, and assistance in responding to demands, liability allegations and lawsuits.

That means litigation infrastructure is part of the management architecture.

But claims administration is not automatically the same thing as:

• physician employment authority;

• corporate ownership;

• or clinical control.

This investigation will treat claims and defense as their own authority domain.

Layer twelve: the current Wellpath description#

Wellpath’s March 2026 California operating-division announcement provides a useful modern cross-check.

Wellpath publicly calls CFMG:

• a Wellpath affiliate;

• a professional corporation;

• owned by licensed physicians;

• affiliated with Wellpath’s MSO.

It also describes California operations as leveraging enterprise data infrastructure across Wellpath affiliates. Wellpath, Mar. 13, 2026

That description is consistent with the broad architecture reflected in the older MSA:

professional corporation + management platform .

The remaining question is how that architecture functions in practice.

Master reader orientation#

The final project conclusion is not that CFMG and Wellpath are “the same entity,” nor that they are operational strangers.

The record supports a layered model:

• CFMG — legally distinct California professional corporation; formal County contractor and strong formal physician-employer evidence; claimed physician-governance authority.

• Wellpath / management entities — extensive MSO/enterprise infrastructure across HR, systems, compensation, credentialing administration, finance, claims, records, litigation, and other operational domains.

• County/client authority — an independent source of contract, security, access, transportation, remedial-plan, and operational requirements.

• Individual licensed clinicians — patient-specific professional judgment and other physician-reserved functions.

The final unresolved issue is function-specific:

When an administrative process reached a decision California reserves to physicians, who possessed practical final approval or veto, and what happened when CFMG and Wellpath disagreed?

December 31, 2012 Management Services Agreement#

An executed Management Services Agreement dated December 31, 2012 is the most important structural document identified so far.

The agreement contains substantial language favoring legality:

• CFMG and the management company are described as separate independent entities.

• CFMG formally employs or engages physicians.

• Professional medical services and medical judgment are reserved to CFMG.

• The management company is prohibited from itself practicing medicine or directly assuming patient-care responsibility.

• The relationship is framed as administrative support rather than professional control.

Those provisions must be given genuine weight.

At the same time, the agreement creates a deeply integrated administrative relationship. The management company is made CFMG's exclusive management-services provider and receives broad responsibilities involving:

• accounting and financial administration;

• payroll and tax functions;

• employee and physician benefit administration;

• physician-employment documentation and policy administration;

• human-resources support;

• staffing analysis;

• physician compensation administration and recommendations;

• billing and coding support;

• information technology;

• electronic health-record systems and operational records;

• county/client contracting support;

• compliance and licensing support;

• insurance and risk-management functions;

• litigation support;

• purchasing and equipment administration;

• banking and budgeting;

• participation in governance-related processes.

This combination—formal reservation of physician authority plus extensive management-company operational authority—is the structural issue that must be tested against actual conduct.

National vertical management model — research hypothesis#

A recurring feature of the Wellpath model is national vertical management. Public corporate materials describe a large multi-state enterprise headquartered in Tennessee. Operational records and employment communications in the public record indicate that California functions were frequently administered through Wellpath executives, HR personnel, legal/risk personnel, and clinical leadership outside the local county facilities.

The relevant issue is not geography. A physician executive may lawfully supervise clinicians from another state, and an MSO may lawfully centralize administrative services. The relevant issue is authority .

the record should test the following hypothesis:

CFMG physicians may have held formal professional-corporation offices while substantial day-to-day operational authority flowed vertically through Wellpath's national or regional chain of command, with local jail physicians and healthcare staff reporting through Wellpath-managed operational structures.

This hypothesis must be tested county by county and function by function.

The evidence required includes:

• organizational charts by year;

• reporting lines for physicians, nursing, mental health, pharmacy, and dental services;

• job descriptions for HSA, DON, site medical director, regional medical director, state medical director, chief medical officer, and operations executives;

• authority matrices;

• policy approval metadata;

• EHR access-control records;

• compensation approval chains;

• disciplinary/termination workflows;

• county-facing escalation protocols;

• CFMG board minutes showing actual physician deliberation.

THE OVERRIDE TEST#

The most probative evidence of genuine physician independence may be actual conflict outcomes .

For each protected area, the record should look for instances where Wellpath and CFMG did not initially agree.

Then ask:

• Who proposed the action?

• Who objected?

• Who had formal approval rights?

• Who had practical veto rights?

• Whose position ultimately prevailed?

• Was the result documented as a CFMG physician decision?

• Could Wellpath implement the opposite result anyway?

Examples of highly probative records:

• CFMG physician rejects Wellpath HR termination recommendation;

• CFMG medical director refuses operations-imposed patient quota;

• CFMG physician approves referral after Wellpath administrative denial;

• CFMG board changes compensation model proposed by MSO;

• CFMG shareholder refuses proposed policy;

• Wellpath cannot replace or discipline physician decision-maker.

A lawful structure should produce at least some observable evidence of independent exercise of authority, especially over many years and many counties.

Absence of such records would not by itself prove sham governance, but it would increase the importance of the contractual control mechanisms.

B. The same agreement gives the management organization extensive physician-facing powers#

The agreement simultaneously grants or contemplates substantial management-company participation in functions close to the professional boundary.

For physician staffing, the management company reviews and recommends the appropriate number of physicians, even though the final determination is expressly CFMG’s.

For physician employment agreements, CFMG is the formal employer, but the agreement provides that physician employment agreements are to be substantially in a form prepared by the management company and approved by CFMG . CFMG may not amend that standard form without the management company’s prior written approval. Materially similar restrictions apply to independent-contractor physician agreements.

Exhibit B provides physician HR services including employment-policy guidance, preparation of physician employment agreements, background checks, orientation, access/database onboarding, benefit administration, employment-law compliance, nonclinical coordination, databases, and software education.

It also states that the management company will consult on physician performance standards, review/propose changes to physician agreements, participate in staffing deliberations, review staffing and coverage schedules, recruit physicians in consultation with CFMG, recommend compensation models, and determine physician and other healthcare-professional base and incentive compensation .

That last provision is especially important.

It is not, by itself, a finding of unlawful corporate practice. Compensation administration can be an ordinary management function. But when read together with CFMG’s formal status as the physician employer, it creates an objectively testable authority question:

What did “determine” mean in actual practice, and what CFMG physician approval, veto, or modification authority existed?

Domain two — physician compensation#

The MSA’s compensation language deserves more attention than it has received in ordinary correctional-health litigation.

Exhibit B says the management company will recommend physician compensation models and determine physician base and incentive compensation .

At the same time, Exhibit B generally states that management services are provided in consultation with CFMG and at CFMG’s ultimate direction and discretion. Those provisions must be read together.

Compensation is not automatically a medical decision. It becomes professionally significant if used to influence patient volume, referrals, testing, transfers, offsite specialty care, productivity, documentation, or time spent per patient.

The Medical Board’s historical enforcement materials have treated compensation structure as one possible indicator when assessing whether a physician is substantively subordinate to a lay entity.

The correct inquiry is therefore:

Did the management organization merely administer commercially agreed compensation, or could it set physician economic incentives that affected protected clinical judgment?

Compensation and deferred-benefit administration for professional-corporation physicians is, under the management services agreement, a management-side function. Whether that administration ever displaced a professional-corporation decision on physician compensation is a question the public record does not answer.

The source records to obtain are compensation matrices, approval metadata, CFMG board resolutions, salary offers, raise approvals, bonus formulas, parity adjustments, and benefit-plan adoption records.

Current assessment: Management-company contractual role is very strong; event-level proof of CFMG approval or override remains incomplete.

Override Test: Find a compensation decision proposed by Wellpath that CFMG physician leadership rejected or modified.

Current event coding#

Chapman termination: Level 2–3. Wellpath participation is sworn; CFMG final approval unclear.

Fresno physician workload concerns: Level 1–2 based on contemporaneous firsthand record; independent verification needed.

Utilization management: Level 2 by Wellpath’s public statement and MSA; patient-specific final authority unknown.

Quality/mortality review: CFMG authority evidence Level 2–3; committee governance still needed.

Physician compensation: strong contractual authority language; event proof Level 1–2 until actual compensation decisions are traced.

EHR/records: technical authority Level 2–3; professional-content authority unresolved.

Strongest evidence justifying further control investigation#

Conversely, several facts justify deeper investigation:

• The MSO is CFMG’s exclusive management-services provider.

• A management representative can attend and participate in CFMG equityholder/governance meetings, though without vote.

• CFMG physician employment forms are prepared by management and cannot be amended without management approval.

• The MSA assigns extensive physician HR functions to management.

• The MSA says management will determine physician base and incentive compensation .

• Management participates in staffing deliberations and schedule review.

• Wellpath publicly says it provides CFMG utilization-management functions.

• Management administers EMR systems and supervises storage/maintenance of patient records.

• Management negotiates client agreements and professional-service agreements on CFMG’s behalf.

• Management acquires/holds title to substantial equipment and recommends medical equipment.

• CFMG designated a Wellpath HR executive as Rule 30(b)(6) PMK about a CFMG physician termination.

• That witness testified the physician was terminated by management working for Wellpath.

• The Wellpath enterprise handbook is broad enough on its face to include entities managed by Wellpath LLC, while its exact application to CFMG physicians remains unresolved.

• Contemporaneous California operating records show Wellpath HR, clinical leadership, insurance, claims, and enterprise systems interacting directly with CFMG physician matters.

• The 2019 assignment transferred the MSA together with related stock-transfer restriction agreements into the Wellpath structure.

These facts do not establish illegality. They establish why approval and override evidence is essential.

Cfmg's termination rights are real, but narrowly structured#

Section 5.2 permits CFMG to terminate immediately if the management company materially breaches the MSA, fails to cure within 45 days after written notice, and the breach materially adversely affects CFMG.

The required notice must be executed by the Company Designee to be effective.

CFMG can also terminate if the management company enters specified insolvency proceedings.

This is meaningful termination authority.

It is evidence against an assertion that CFMG had literally no contractual exit right.

But several structural features narrow that freedom.

First, the agreement does not appear to provide CFMG a broad termination-for-convenience right during the term.

Second, CFMG's breach notice must come from the Company Designee.

Third, the management company has its own termination rights.

Fourth, termination of the Deficit Funding Loan Agreement gives the management company an immediate termination right under the MSA.

Fifth, certain breaches can trigger substantial payment consequences.

Accordingly, the proper question is not whether CFMG had some termination right.

It is:

Could the physician corporation realistically choose a new MSO simply because its physicians preferred a different manager?

On the current text, that proposition is not established.

Wellpath’s Chapter 11 case is the strongest natural experiment yet for testing the CFMG–Wellpath relationship.

The reason is straightforward.

Before bankruptcy, extensive operational integration could coexist with imprecise nomenclature because there was often little immediate reason for counties, clinicians, litigants, or courts to distinguish the professional corporation from the management enterprise with precision.

Bankruptcy changed that.

Once Wellpath entered Chapter 11:

• debtor and nondebtor status mattered;

• property of the estate mattered;

• executory-contract rights mattered;

• insurance and indemnity mattered;

• ownership and contract rights mattered;

• the identity of the professional corporations mattered;

• the ability to continue management relationships mattered;

• and the transition from H.I.G.-sponsored ownership to lender ownership mattered.

The bankruptcy record therefore forced Wellpath to explain its professional-corporation architecture in pleadings filed before a federal bankruptcy court.

The result is unusually revealing.

Wellpath’s own November 12, 2024 Professional Corporation Motion described the nationwide structure as a “friendly professional corporation” structure . The Debtors said the professional corporations were owned exclusively by licensed physicians affiliated with the Debtors , while the Debtors exercised certain control over the nonclinical business-management and administrative functions. At the same time, the Debtors disclosed that:

• the 18 professional corporations collectively generated more than $674 million in 2023 revenue “for the benefit of the Debtors” ;

• the Debtors and certain physician owners were parties to Stock Transfer Agreements restricting transfer of professional-corporation stock;

• those restrictions were intended not only to maintain state-law compliance and continuity of care but also to preserve the continuation of administrative services by the Debtors ;

• under those Stock Transfer Agreements, the Debtors had authority to ensure that the professional corporations remained duly licensed and qualified;

• in 2023 the Debtors remitted approximately $720 million to physician owners and vendors as professional-corporation operating costs;

• the Debtors collected certain professional-corporation receivables and deposited them into professional-corporation accounts;

• the Debtors considered the professional-corporation relationships indispensable to the success of their own reorganization.

Most strikingly, the same motion later said that the Debtors “maintain an interest in the Professional Corporations” and referred to revenue derived pursuant to the Debtors’ “ownership interests in the Professional Corporations.”

That latter language is facially difficult to reconcile with the same pleading’s statement that the professional corporations were owned exclusively by licensed physicians .

this record does not treat that wording as proof that Wellpath owned CFMG stock.

The phrase may reflect:

• imprecise bankruptcy advocacy;

• an economic or contractual “interest” rather than stock ownership;

• differences among the 18 professional corporations;

• or drafting shorthand that did not carefully distinguish equity from contractual rights.

The court did not conduct a trial determining that Wellpath owned CFMG.

But the wording is too important to ignore.

It creates one of the strongest internal-document contradictions found in this investigation and sharply increases the importance of the actual CFMG stock-transfer agreements.

Compensation — Wellpath administration, final authority still to be traced#

The 2024 compensation emails are useful because they show the practical route by which a Fresno physician sought a pay adjustment.

In August and September 2024:

• communications went to Wellpath personnel at @wellpath.us ;

• Linda Matlock advised that she was working with a regional vice president on how the rate could be adjusted;

• Heather Barry later stated that Linda was working with Terry on that quarter's compensation file;

• the physician described a five-year compensation increase he understood HR had represented would begin October 1, 2024.

This is strong evidence that Wellpath's HR/operations infrastructure administered compensation review .

But the emails do not yet show:

• who possessed contractual authority to change the CFMG physician's rate;

• whether a CFMG physician officer approved compensation;

• whether County contract economics constrained the rate;

• whether the five-year increase was automatic, discretionary, or subject to an approval matrix;

• or whether Wellpath merely prepared the compensation file for CFMG approval.

The correct discovery target is the actual compensation-approval workflow:

request → market review → regional recommendation → compensation committee or authorized approver → CFMG approval if required → payroll implementation.

The most probative records would be approval metadata, not email branding.

The 2012 management-agreement baseline#

Earlier articles in this series identified the December 31, 2012 Management Services Agreement as the central structural instrument in the modern CFMG–MSO arrangement.

The reviewed project record attributes to that agreement several provisions favoring a lawful PC–MSO architecture:

• CFMG and the management organization are described as separate entities;

• CFMG formally employs or engages physicians;

• professional medical services and medical judgment are reserved to CFMG;

• the management organization is not itself to practice medicine or assume direct patient-care responsibility;

• broad administrative services are delegated to the management side.

The same record describes the management organization as having extensive responsibilities concerning:

• payroll and benefits administration;

• physician-employment documentation;

• HR support;

• staffing analysis;

• compensation administration and recommendations;

• billing and coding support;

• IT and electronic-record systems;

• insurance and risk;

• litigation support;

• contracting;

• purchasing and equipment;

• finance, banking, and budgeting;

• and participation in governance-related processes.

A project submission that reviewed the executed agreement also identifies a potentially important “Company Designee” mechanism, under which certain CFMG actions or approvals may be communicated through a designated CFMG officer or designee and relied upon by the management organization as CFMG action.

That mechanism is not inherently improper. But it makes authentication of the approval chain essential. If CFMG decisions were routinely transmitted through one designee, the investigation must know:

• who held that role at each relevant time;

• whether the designee was a licensed physician;

• what authority had been delegated;

• whether professional decisions could be delegated at all;

• what record showed the underlying physician decision;

• and whether the MSO could act without obtaining a fresh CFMG approval.

The MSA therefore provides the formal hypothesis. the prior analysis tests whether actual conduct matched it.

Evidentiary caution: the standalone executed 2012 MSA has not yet been separately indexed in the current saved Library under an obvious filename. the investigation's existing section-by-section crosswalk should be treated as a strong retrieval guide, while the executed agreement, exhibits, assignments, amendments, and designee records remain Tier-One authentication targets.

Medical director authority — title is not enough#

The term “Medical Director” can conceal several legally different roles.

A physician may be:

• a site medical director for the Fresno County jail;

• a regional medical director;

• a national Wellpath physician executive;

• a CFMG officer or director;

• an MSO-employed physician providing management services;

• a member of a CFMG physician board;

• a credentialing or quality reviewer;

• or some combination of those roles.

the investigation must therefore stop treating “medical director” as a self-executing answer to control.

For every physician leader involved in a disputed event, the record should identify:

• employing entity;

• corporate office, if any;

• California license status;

• written appointment;

• written delegation;

• reporting line;

• scope of clinical authority;

• scope of HR authority;

• authority to bind CFMG;

• authority to approve or reject Wellpath recommendations;

• authority over privileging/credentialing;

• authority over peer review and section 805 reporting;

• authority over physician schedules and patient volume;

• authority over referral/utilization disputes;

• and evidence of actual exercise of those powers.

Dr. Dheeraj Taranath's April 2025 communication is especially relevant. He described Wellpath as the management services organization contracted to provide the “full range of administrative services” to CFMG and represented that matters raised by the physician had been reviewed with CFMG leadership and that Wellpath communications proceeded with CFMG leadership's knowledge and approval.

That communication supports two competing inferences.

Defense inference: Wellpath was operating as an MSO and took recommendations to CFMG leadership, which retained approval.

Investigative inference: Wellpath may have functioned as the practical decision engine, with CFMG leadership providing approval after recommendations had already been developed.

The distinction cannot be resolved from phrasing alone. The underlying approval records are needed.

Why an override census is more probative than a control narrative#

The phrase “who controlled CFMG?” is too broad to be useful without identifying the function, time, site, and decision.

A professional corporation can lawfully delegate or outsource administrative implementation while retaining protected professional authority. A management organization can also influence outcomes without formally owning the professional decision. The only reliable way to distinguish the two is to reconstruct concrete events.

For each event the record now asks:

• What triggered the decision?

• Who opened the workflow?

• Who developed the factual record?

• Who recommended an outcome?

• Was a professional review required?

• Which licensed physician or physician body performed that review?

• Could that reviewer reject the recommendation?

• Did the reviewer ever ask questions, delay action, impose conditions, modify reasoning, dissent, or say no?

• Who entered the final decision into the operational system?

• Did implementation occur before or after professional approval?

• What happened when the professional and administrative participants disagreed?

The last question is the most valuable.

If Wellpath recommends termination and a CFMG physician body rejects termination, and the physician remains employed, the event strongly supports practical CFMG veto power. If Wellpath proposes a workload target and a CFMG medical director reduces it for safety reasons, and the reduced target governs despite financial cost, that is strong evidence of professional independence. If a Wellpath utilization mechanism initially denies an outside referral and a CFMG physician reverses the denial, that can show physician authority over patient-specific care.

The reverse matters too. If a CFMG physician rejects an administrative recommendation but Wellpath proceeds anyway, or if Wellpath implements a clinically sensitive action before any CFMG physician review, that would weigh in the opposite direction.

Routine concurrence has much less discriminatory value. A physician can agree with an MSO recommendation for legitimate reasons. A long series of unanimous decisions proves little unless the record also shows that disagreement was practically possible.

B. The MSA creates structural dependence even while reserving professional judgment#

The control theory gives full credit to the MSA's professional-independence clauses.

Then it asks whether the rest of the architecture made independent exercise difficult in practice.

Potentially significant features identified in the investigation include:

• exclusive management;

• management participation in governance meetings;

• Company Designee mechanics;

• financial administration;

• bank-payment rights;

• broad security interests;

• staffing analysis;

• physician compensation administration;

• records and IT systems;

• employment-document administration;

• related stock-transfer restrictions referenced in assignment documents.

None independently proves CPOM.

Together they justify investigation of practical dependency.

IV. Contrary Evidence, Limits, and Competing Explanations#

A disciplined analysis must begin its limiting case with the strongest contrary evidence: The strongest contrary evidence is the MSA's explicit reservation of professional authority and real termination rights. The article must distinguish structural leverage from proof of an actual unlawful medical decision.

B. The 2012 MSA is substantial exculpatory evidence#

the investigation-reviewed MSA contains precisely the provisions one would expect in a lawful California PC–MSO architecture:

• separate-entity language;

• professional independence language;

• formal physician employment by CFMG;

• reservation of professional medical judgment;

• prohibitions on the manager practicing medicine;

• broad but defined administrative services.

The defense should insist that these provisions are not "mere paper."

Contracts are evidence of intended and allocated authority.

A regulator cannot infer that every contractual boundary was ignored merely because the MSO performed many administrative functions.

The agreement's use of an exclusive manager is also not inherently unlawful. Large practices often centralize systems and support functions for efficiency. Exclusivity may be commercially important without transferring professional rights.

V. Missing Documents and Falsification Tests#

The record remains incomplete in material respects. Key unresolved points include Company Designee history, practical MSO replacement, compensation veto, and an actual event where formal professional authority changed management's preferred outcome.

Layer ten: management fee, credit and collateral#

The filed agreement refers to:

• the management fee;

• a Deficit Funding Loan Agreement;

• broader credit relationships;

• and a security interest in company assets to the extent permitted by law.

The underlying financial documents are important because they may show the practical economic relationship between CFMG and the manager.

The MSA alone does not establish whether those mechanisms were ordinary commercial protections or whether they materially constrained CFMG’s ability to operate independently.

That is an open-document question.

Layer eleven: the 2019 assignment and stock-transfer restrictions#

The January 2019 assignment is one of the most consequential public documents.

It transferred the management agreement to Wellpath LLC.

It also says the assignment included related or incidental instruments, including relevant stock transfer restriction agreements .

That phrase should be handled with care.

It establishes a documentary trail.

It does not establish what rights the stock-transfer instruments contained.

The public investigation should therefore resist the temptation to fill the gap with facts from unrelated “friendly PC” cases.

Instead, the proper question is simple:

What do the CFMG-specific stock-transfer and succession documents actually say?

Until those documents are located, the answer remains open.

The next evidentiary step#

The management agreement gives the investigation a roadmap.

The next phase is to look for public “natural experiments” — situations where:

• management recommended one result;

• physician authority wanted another;

• and one side’s decision controlled implementation.

That kind of disagreement evidence is more informative than another hundred examples of routine cooperation.

The central question remains:

Who could say no — and did the other side have to listen?

The “real disagreement” test remains the gold standard#

Even after the stock agreement is obtained, actual conduct will remain important.

The best evidence of real independence would be a documented disagreement in which:

• Wellpath wanted one result;

• the CFMG physician owner/board wanted another;

• the physician decision prevailed;

• and the physician did not lose employment, ownership, or corporate authority.

Examples could include:

• rejecting a termination recommendation;

• rejecting a patient-volume target;

• modifying compensation;

• approving a referral despite cost concerns;

• refusing an enterprise clinical policy;

• replacing an MSO executive liaison;

• withholding a management bonus.

The best evidence of capture would be the opposite:

• physician resists;

• Wellpath threatens/uses stock or employment rights;

• physician is replaced;

• decision changes.

This is why contract rights and real-world events must ultimately be paired.

VI. Why the Issue Matters#

The stakes are practical rather than semantic. Counties need to know which entity is accountable for contracted performance; clinicians need to know where professional authority resides; courts and regulators need entity-specific evidence rather than brand shorthand; and the public needs a record that distinguishes corporate continuity from operational integration. Those distinctions become most important when the actors disagree, when a contract changes hands, when a professional decision conflicts with an economic preference, or when litigation requires a precise answer to who had authority to act.

CFMG predates Wellpath by decades#

H.I.G. Capital’s January 2013 announcement described CFMG as a California correctional-healthcare company founded in 1983 and operating across the state. H.I.G. announced that an affiliate had made a strategic investment in the company. The release identified CFMG’s then-president and medical director, Dr. Taylor Fithian, and described the company as a provider of outsourced healthcare to county jails. Source: H.I.G. Capital, Jan. 7, 2013

That announcement is important, but it should be read narrowly. It establishes an investment relationship. It does not , by itself, establish that H.I.G. directly acquired the shares of the California professional corporation or identify CFMG’s shareholder structure after the transaction.

What the Medical Board says physicians must control#

The Medical Board of California’s current corporate-practice guidance makes the line unusually concrete.

The Board says the doctrine is intended to prevent unlicensed persons from interfering with or influencing professional judgment. It identifies several healthcare decisions that should be made by California-licensed physicians:

• appropriate diagnostic testing;

• referrals and specialist consultation;

• responsibility for the patient’s ultimate overall care and treatment options;

• how many patients a physician must see;

• how many hours a physician must work.

The Board then identifies additional “business” or “management” decisions that can amount to control of medical practice, including:

• control of medical records and their contents;

• physician and clinical-staff hiring or firing when clinical competency or proficiency is involved;

• parameters for payer relationships;

• coding and billing procedures;

• selection of medical equipment and supplies.

Medical Board of California — Practice Information

That list is crucial because it prevents two analytical mistakes.

Layer six: physicians are employed or engaged by CFMG — but management shapes the employment architecture#

The agreement says CFMG employs or engages the physicians necessary for the practice.

That is formal evidence of CFMG’s employer role.

But the employment architecture is shared.

The agreement provides that forms of physician employment agreements are prepared through the management organization and approved by CFMG. It further states that CFMG may not amend the form without the manager’s prior written approval.

The manager also provides extensive physician HR support, including categories such as:

• employment policies and forms;

• background-check support;

• orientation;

• benefits administration;

• workers’ compensation and EEO-related administration;

• software education;

• physician database maintenance.

This is a particularly useful example of why “who is the employer?” and “who administers employment?” are not always the same question.

The public contract places CFMG in the physician-employer position while giving the manager a major role in the employment infrastructure.

VII. Falsification Tests and Evidentiary Limits Note#

The record does not support be read as establishing an unproven motive, an undisclosed shareholder, an unlawful medical override, or a legal conclusion that a court or regulator has not made. The strongest version of the thesis is the one that survives the missing-document test: identify the instrument, minutes, ledger, delegation, approval record, or disagreement event that would materially change the conclusion, then state what has and has not been found. If later primary evidence contradicts a proposition stated here, the correction should be made at the proposition level rather than defended through branding or organizational shorthand.

VIII. Related Articles#

• Article 014 — Who Designs the Physician Employment Contract? CFMG, Wellpath, and the Employment-Form Architecture

• Article 016 — The 18 Percent Question: What the Management Fee Says About Economic Integration

• Article 013 — The Company Designee: The Little-Studied Office at the Center of CFMG Approval

The proposition to be tested#

The central proposition in this article is not that every appearance of the Wellpath name proves control, nor that formal CFMG separateness ends the inquiry. The proposition to be tested is narrower: When does administrative compensation design become relevant to physician autonomy? A serious legal brief should state that proposition before discussing motive, liability, or remedy because the same document can be highly probative on one dimension and nearly irrelevant on another.

For this subject, the principal evidentiary dimensions are physician compensation, economic leverage, professional autonomy, and management recommendations. The source spine identified in the current public record is: MSA compensation exhibits; management recommendation/determination language; pay practices; missing override examples. Those sources should not be pooled as though they were interchangeable. A county contract speaks most reliably to the county's counterparty and purchased obligations. A management agreement speaks to contractual allocation between the professional corporation and manager. A court order speaks to the matter actually adjudicated. A party filing or corporate announcement remains a representation unless independently adopted or found by a tribunal.

A management-services agreement must be read function by function. Administrative delegation is not synonymous with delegation of professional judgment. The evidentiary task is to identify the exact contractual reservation, the exact management power, and the real-world implementation record when those provisions came into tension. The practical advantage of that method is that it prevents a common failure in complex-enterprise investigations: using a true fact about one relationship as proof of a different relationship. A shared brand may show integration; a W-2 may show payroll identity; a contract signature may show authority to bind a corporation; an officer title may show corporate office. None automatically proves stock ownership or final clinical authority.

The charging or enforcement threshold, if any regulator ever considered one, would therefore require an evidence chain rather than a collage: identify the protected or regulated function; identify the actor with formal authority; reconstruct the first operative decision; identify the person or entity that could approve, reject, modify, or reverse it; and verify who implemented the result. Until that chain is complete, the proper classification is evidence, inference, or unresolved question—not adjudicated fact.

Weighing the evidence#

The evidentiary hierarchy for Physician Pay as a Control Boundary: Compensation Inside the CFMG–Wellpath MSA should begin with contemporaneous primary instruments and end with retrospective shorthand. Executed contracts, amendments, assignments, board resolutions, authenticated corporate records, court orders, government payroll or labor records, and formal agency records ordinarily deserve more weight on the proposition they were created to establish than marketing language or later summaries. Even among primary materials, however, purpose matters. A contract can establish contractual rights without proving that those rights were exercised; a tax record can establish reporting without deciding every common-law employer factor; a bankruptcy schedule can establish debtor treatment without answering professional-governance questions for a nondebtor corporation.

The article's existing record illustrates why that hierarchy matters.ntiary lane. Physician Pay as a Control Boundary: Compensation Inside the CFMG–Wellpath MSA turns on the difference between authority written on paper and authority demonstrated in operation. The analysis reads the management-services architecture as a division of functions, then tests whether the economic and administrative structure supports, constrains, or leaves unanswered the professional authority formally reserved to CFMG.

A prosecutor, defense lawyer, regulator, or investigative editor should ask five questions of every source: Who created it? What legal or business purpose did it serve? What date and entity does it concern? Is the statement a recital, operative term, allegation, stipulation, finding, or marketing representation? What independent record could confirm or contradict it? Applying those questions consistently is more valuable than multiplying citations that all derive from the same underlying assertion.

This also defines how contradictions should be handled. When two records use different labels, the first step is not to accuse one of being false. The first step is to determine whether the records were answering different questions. Only after normalizing entity, date, capacity, forum, and purpose should a remaining contradiction be treated as substantive. That discipline makes the article stronger for both sides because it identifies where the record genuinely conflicts and where the conflict is merely semantic.

Sources and authorities#

1. H.I.G., Oct. 1, 2018 hig.com — https://hig.com/news/correct-care-solutions-and-correctional-medical-group-companies-join-forces-to-deliver-best-in-class-healthcare/
2. Wellpath, Mar. 13, 2026 wellpathcare.com — https://wellpathcare.com/2026/03/13/wellpath-announces-creation-of-a-new-operating-division-in-california-appoints-new-highly-experienced-leader/
3. Source: H.I.G. Capital, Jan. 7, 2013 hig.com — https://hig.com/news/h-i-g-capital-announces-strategic-investment-in-california-forensic-medical-group/
4. Medical Board of California — Practice Information www.mbc.ca.gov — https://www.mbc.ca.gov/Licensing/Physicians-and-Surgeons/Practice-Information/